GDF15 is associated with thyroid cancer progression and may modulate thyroid cancer cell senescence in a p53-dependent manner.

Ma J, Liu Z, Hua R, Ding C, Yang Z, Liang W, Lv B

Open source

DOI
10.3389/fendo.2025.1675245
Published
2025
Container
Frontiers in endocrinology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2025.1675245,
  title = {GDF15 is associated with thyroid cancer progression and may modulate thyroid cancer cell senescence in a p53-dependent manner.},
  author = {Ma J and Liu Z and Hua R and Ding C and Yang Z and Liang W and Lv B},
  year = {2025},
  journal = {Frontiers in endocrinology},
  doi = {10.3389/fendo.2025.1675245},
  url = {https://doi.org/10.3389/fendo.2025.1675245}
}

RIS

TY  - JOUR
TI  - GDF15 is associated with thyroid cancer progression and may modulate thyroid cancer cell senescence in a p53-dependent manner.
AU  - Ma J
AU  - Liu Z
AU  - Hua R
AU  - Ding C
AU  - Yang Z
AU  - Liang W
AU  - Lv B
PY  - 2025
JO  - Frontiers in endocrinology
DO  - 10.3389/fendo.2025.1675245
UR  - https://doi.org/10.3389/fendo.2025.1675245
ER  - 

APA

J, M., Z, L., R, H., C, D., Z, Y., W, L., & B, L. (2025). GDF15 is associated with thyroid cancer progression and may modulate thyroid cancer cell senescence in a p53-dependent manner.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2025.1675245

Source records